Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Aryx Therapeutics, Inc. (ARYX)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aryx Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Aryx Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is ARYX. The reporting company's CIK number is 1410064.
The total value of stock buying since 2005 is $26,798,886.
The total value of stock sales since 2005 is $9,631,285.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2011-03-10||Drant Ryan D (10% Owner)||Sale||4,469,274||.07||326,257|
|2011-03-10||Baskett Forest (10% Owner)||Sale||4,469,274||.07||326,257|
|2011-03-10||Kolluri Krishna Kittu (10% Owner)||Sale||4,469,274||.07||326,257|
|2011-03-10||Sandell Scott D (10% Owner)||Sale||4,469,274||.07||326,257|
|2011-03-10||Kerins Patrick J (10% Owner)||Sale||4,469,274||.07||326,257|
|2009-05-22||Isaly Samuel D (10% Owner)||Sale||2,000,000||4.00||8,000,000|
|2008-11-14||Mpm Bioventures Strategic Fund Lp (10% Owner)||Buy||1,787,710||2.20||3,932,962|
|2008-11-14||Adelman Robert J||Buy||1,214,646||.00||0|
|2008-11-14||Wheeler Kurt (10% Owner)||Buy||1,787,710||2.20||3,932,962|
|2008-11-14||Simon Nicholas J Iii (Director)||Buy||1,787,710||2.20||3,932,962|
|2008-11-14||Isaly Samuel D||Buy||1,214,646||.00||0|
|2007-11-13||Mpm Bioventures Strategic Fund Lp (10% Owner)||Buy||300,000||10.00||3,000,000|
|2007-11-13||Adelman Robert J (Director)||Buy||300,000||10.00||3,000,000|
|2007-11-13||Wheeler Kurt (10% Owner)||Buy||300,000||10.00||3,000,000|
|2007-11-13||Simon Nicholas J Iii (Director)||Buy||300,000||10.00||3,000,000|
|2007-11-13||Isaly Samuel D (Director)||Buy||300,000||10.00||3,000,000|
Insider trading activities including stock purchases, stock sales, and option exercises of ARYX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aryx Therapeutics, Inc. (symbol ARYX, CIK number 1410064) see the Securities and Exchange Commission (SEC) website.